PREVECEUTICAL MEDICAL INC (PRVCF:OTCMKTS)
$0.0102 0 (0%)
Analysed PREVECEUTICAL MEDICAL INC (PRVCF:OTCMKTS) News Sources
PreveCeutical Announces Filing of Patent for Delivery of CNS-Active Agents
09-02-2026
yahoo.com
PreveCeutical Announces Canadian Patent Office Allowance of Innovative Pain Therapy Technology
25-02-2026
yahoo.com
BioGene Therapeutics Inc. Appoints Raj S. Pruthi, MD, MHA, FACS, as Director
12-03-2026
yahoo.com
PreveCeutical Medical Inc. Appoints Raj S. Pruthi, MD, MHA, FACS, as Director
30-03-2026
yahoo.com
PreveCeutical Adopts Semi-Annual Financial Reporting
01-04-2026
yahoo.com
PreveCeutical Announces Non-Brokered Private Placement
22-04-2026
yahoo.com
PreveCeutical Closes Initial Tranche of Non-Brokered Private Placement
12-05-2026
yahoo.com
PreveCeutical Announces Extension of Non-Brokered Private Placement
19-05-2026
yahoo.com
BioGene Therapeutics Inc. Appoints Ty Howton to Board of Directors
08-06-2026
yahoo.com
PreveCeutical Closes Second Tranche of Non-Brokered Private Placement
12-06-2026
yahoo.com
What is the current price of PREVECEUTICAL MEDICAL INC (PRVCF:OTCMKTS)?
The current price of PREVECEUTICAL MEDICAL INC (PRVCF:OTCMKTS) is $0.0102.
PREVECEUTICAL MEDICAL INC (PRVCF:OTCMKTS) absolute price change since previous trading day?
The absolute price change of PREVECEUTICAL MEDICAL INC (PRVCF:OTCMKTS) since the previous trading day is $0.
PREVECEUTICAL MEDICAL INC (PRVCF:OTCMKTS) percentage price change since previous trading day?
The percentage price change of PREVECEUTICAL MEDICAL INC (PRVCF:OTCMKTS) since the previous trading day is 0%.
What is the most recent average sentiment score for PREVECEUTICAL MEDICAL INC (PRVCF:OTCMKTS)?
The most recent average sentiment score for PREVECEUTICAL MEDICAL INC (PRVCF:OTCMKTS) is 53 out of 100.
What is the most recent average sentiment for PREVECEUTICAL MEDICAL INC (PRVCF:OTCMKTS)?
The most recent sentiment for PREVECEUTICAL MEDICAL INC (PRVCF:OTCMKTS) is .
SEC-8K** Filing Available For PREVECEUTICAL MEDICAL INC (PRVCF:OTCMKTS)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.